Bessemer Group’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-27,585
| Closed | -$187K | – | 2087 |
|
|
2022
Q1 | $187K | Buy |
27,585
+15,718
| +132% | +$107K | ﹤0.01% | 841 |
|
|
2021
Q4 | $99K | Hold |
11,867
| – | – | ﹤0.01% | 1005 |
|
|
2021
Q3 | $88K | Hold |
11,867
| – | – | ﹤0.01% | 962 |
|
|
2021
Q2 | $81K | Hold |
11,867
| – | – | ﹤0.01% | 986 |
|
|
2021
Q1 | $122K | Buy |
11,867
+1,700
| +17% | +$17.5K | ﹤0.01% | 856 |
|
|
2020
Q4 | $71K | Buy |
+10,167
| New | +$71K | ﹤0.01% | 931 |
|